122 related articles for article (PubMed ID: 10201988)
21. Localization to chromosome 22 of a gene encoding a human minor histocompatibility antigen.
Gubarev MI; Jenkin JC; Leppert MF; Buchanan GS; Otterud BE; Guilbert DA; Beatty PG
J Immunol; 1996 Dec; 157(12):5448-54. PubMed ID: 8955193
[TBL] [Abstract][Full Text] [Related]
22. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
23. Complexity of the histocompatibility-3 region in the mouse.
Rammensee HG; Klein J
J Immunol; 1983 Jun; 130(6):2926-9. PubMed ID: 6189905
[TBL] [Abstract][Full Text] [Related]
24. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
25. Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex.
Zuberi AR; Christianson GJ; Mendoza LM; Shastri N; Roopenian DC
Immunity; 1998 Nov; 9(5):687-98. PubMed ID: 9846490
[TBL] [Abstract][Full Text] [Related]
26. CTL induction by cross-priming is restricted to immunodominant epitopes.
Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
[TBL] [Abstract][Full Text] [Related]
27. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.
Sugimoto K; Murata M; Terakura S; Naoe T
J Immunol; 2009 Nov; 183(9):5991-8. PubMed ID: 19812210
[TBL] [Abstract][Full Text] [Related]
28. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.
Rufer N; Wolpert E; Helg C; Tiercy JM; Gratwohl A; Chapuis B; Jeannet M; Goulmy E; Roosnek E
Transplantation; 1998 Oct; 66(7):910-6. PubMed ID: 9798702
[TBL] [Abstract][Full Text] [Related]
29. Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k mice.
Huseby ES; Ohlén C; Goverman J
J Immunol; 1999 Aug; 163(3):1115-8. PubMed ID: 10415003
[TBL] [Abstract][Full Text] [Related]
30. The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303.
Torikai H; Akatsuka Y; Miyazaki M; Tsujimura A; Yatabe Y; Kawase T; Nakao Y; Tsujimura K; Motoyoshi K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Br J Haematol; 2006 Aug; 134(4):406-16. PubMed ID: 16822283
[TBL] [Abstract][Full Text] [Related]
31. Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8+ cytotoxic lymphocyte population.
Kalergis AM; Ono T; Wang F; DiLorenzo TP; Honda S; Nathenson SG
J Immunol; 1999 Jun; 162(12):7263-70. PubMed ID: 10358174
[TBL] [Abstract][Full Text] [Related]
32. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
33. Gene mapping in a murine cell line by immunoselection with cytotoxic T lymphocytes.
Zuberi AR; Dudley ME; Christianson GJ; Roopenian DC
Genomics; 1994 Jan; 19(2):273-9. PubMed ID: 7514566
[TBL] [Abstract][Full Text] [Related]
34. The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3.
Morse MC; Bleau G; Dabhi VM; Hétu F; Drobetsky EA; Lindahl KF; Perreault C
J Immunol; 1996 May; 156(9):3301-7. PubMed ID: 8617953
[TBL] [Abstract][Full Text] [Related]
35. Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens.
Malarkannan S; Horng T; Eden P; Gonzalez F; Shih P; Brouwenstijn N; Klinge H; Christianson G; Roopenian D; Shastri N
Immunity; 2000 Sep; 13(3):333-44. PubMed ID: 11021531
[TBL] [Abstract][Full Text] [Related]
36. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
37. A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.
Sireci G; Barera A; Macaluso P; Di Sano C; Bonanno CT; Pio La Manna M; Di Liberto D; Dieli F; Salerno A
Immunobiology; 2009; 214(8):703-11. PubMed ID: 19249121
[TBL] [Abstract][Full Text] [Related]
38. A locus on chromosome 2 influences the development of acute graft-versus-host disease in a murine model.
Harper JM; Slayback DL; Dobkins JA; Allen RD
Bone Marrow Transplant; 1999 Jun; 23(11):1183-90. PubMed ID: 10382959
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA
Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751
[TBL] [Abstract][Full Text] [Related]
40. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H
Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
